Demo Data from EDBT 2026 / reviewers in the wild / expert
Hikmet Emre Kaya
dblp:370/6119
· DBLP profile ↗
1ranked-venue papers
1as first author
1since 2021 · last 2023
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 first-author · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 4 heaviest of 4, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › drug discovery › target identification
drug target identification |
0.7 | 1 | 2023 | CytoCopasi: a chemical systems biology target and drug discovery visual data analytics platform · Bioinform. 2023 |
Bioinformatics and computational biology › systems biology
kinetic modeling |
0.7 | 1 | 2023 | CytoCopasi: a chemical systems biology target and drug discovery visual data analytics platform · Bioinform. 2023 |
Bioinformatics and computational biology
systems biology |
0.7 | 1 | 2023 | CytoCopasi: a chemical systems biology target and drug discovery visual data analytics platform · Bioinform. 2023 |
Bioinformatics and computational biology › systems biology
pathway database integration |
0.2 | 1 | 2023 | CytoCopasi: a chemical systems biology target and drug discovery visual data analytics platform · Bioinform. 2023 |
Methods — techniques the papers use, named apart from their topics
visualization · 0.7model construction · 0.7
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2023 | CytoCopasi: a chemical systems biology target and drug discovery visual data analytics platformabstractMOTIVATION: Target discovery and drug evaluation for diseases with complex mechanisms call for a streamlined chemical systems analysis platform. Currently available tools lack the emphasis on reaction kinetics, access to relevant databases, and algorithms to visualize perturbations on a chemical scale providing quantitative details as well streamlined visual data analytics functionality. RESULTS: CytoCopasi, a Maven-based application for Cytoscape that combines the chemical systems analysis features of COPASI with the visualization and database access tools of Cytoscape and its plugin applications has been developed. The diverse functionality of CytoCopasi through ab initio model construction, model construction via pathway and parameter databases KEGG and BRENDA is presented. The comparative systems biology visualization analysis toolset is illustrated through a drug competence study on the cancerous RAF/MEK/ERK pathway. AVAILABILITY AND IMPLEMENTATION: The COPASI files, simulation data, native libraries, and the manual are available on https://github.com/scientificomputing/CytoCopasi. Hikmet Emre Kaya, Kevin J. Naidoo |
Bioinform. | 1 |